Dr. Lawrence Stanton
Director of the Neurological Disorders Research Center at the Qatar Biomedical Research Institute (QBRI)
Dr. Lawrence Stanton is the director of the Neurological Disorders Research Center at the Qatar Biomedical Research Institute (QBRI), under Hamad Bin Khalifa University (HBKU), and a professor at HBKU’s College of Health and Life Sciences. His research is focused on dissecting the molecular pathways that underly neurodevelopmental disorders, including autism.
Dr. Stanton joined QBRI in 2019 with more than 30 years of research experience in industry and academia. At QBRI, the Stanton lab is generating induced pluripotent stem cells (iPSC) from patients with neurodevelopmental disorders. These patient-specific iPSC are converted into neural cell types and organoids, thus providing an opportunity to understand the molecular pathology of diseases such as autism, and establishing a foundation for the development of diagnostics and therapeutics to treat patients with neurodevelopmental disorders.
For his tremendous efforts, Dr. Stanton was awarded President’s Science and Technology Award in Singapore (2011) and UK-Southeast Asia Partnership Award (2014).
After earning a Ph.D. in biochemistry at Stony Brook University (USA), Dr. Stanton completed a post-doctoral fellowship in cancer biology at University of California San Francisco (USA), under the guidance of Nobel Laureate, Dr. Michael Bishop.